April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Topical Naltrexone Reverses Dry Eye in Normal Rats
Author Affiliations & Notes
  • Joseph W. Sassani
    Ophthalmology,
    Penn State College of Medicine, Hershey, Pennsylvania
  • Anna M. Campbell
    Neural & Behavioral Sciences,
    Penn State College of Medicine, Hershey, Pennsylvania
  • Patricia J. McLaughlin
    Neural & Behavioral Sciences,
    Penn State College of Medicine, Hershey, Pennsylvania
  • Ian S. Zagon
    Neural & Behavioral Sciences,
    Penn State College of Medicine, Hershey, Pennsylvania
  • Footnotes
    Commercial Relationships  Joseph W. Sassani, None; Anna M. Campbell, None; Patricia J. McLaughlin, None; Ian S. Zagon, None
  • Footnotes
    Support  ARRA award NIH/NEI EY016666 and EY016666-04S1
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3784. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Joseph W. Sassani, Anna M. Campbell, Patricia J. McLaughlin, Ian S. Zagon; Topical Naltrexone Reverses Dry Eye in Normal Rats. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3784.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Dry eye syndrome is a common condition in aging populations, with an expected incidence of 13% over a 5-year period for persons aged 45 and older. The etiology, pathogenesis, and treatment of dry eye are not completely understood. However, dry eye is often accompanied by superficial punctuate keratopathy that may result in persistent epithelial defect and ulceration. Naltrexone (NTX), an opioid antagonist, has been shown to enhance corneal re-epithelialization in normal rats. The aim of the present study was to determine whether topical application of NTX restores tear production in normal rats with naturally occurring dry eye (i.e., episodic dry eye).

Methods: : Tear production was measured in male (4-24 weeks) Sprague-Dawley rats by the Schirmer’s test. One drop of 10-5 M NTX in Vigamox, or Vigamox alone, was administered. Rats with Schirmer scores of 6.5 or less were defined as having "dry eye". Corneal sensitivity was measured with an aesthesiometer.

Results: : All rats displayed at least one episode of dry eye over the 20 weeks of testing. The mean Schirmer score for rats with dry eye was 5.3 ± 0.1 mm in comparison to a score of 9.1 ± 0.1 mm for animals with normal tear production. Using animals of 9-24 weeks in age, administration of one eye drop of NTX to those rats with dry eye revealed an elevation in Schirmer test scores that was comparable to scores in rats with normal tear production, and this elevation was recorded at 1, 24 and 48 h. At 72 hr, Schirmer test scores for animals with dry eye that received topical NTX returned to baseline values. Animals with dry eye that received topical administration of vehicle did not differ from baseline when tested at 1, 24, 48, or 72 hr. Rats with normal tear production given one drop of NTX or vehicle had Schirmer test scores at 1, 24, 48, or 72 hr that did not deviate from their baseline. Corneal sensitivity of rats with dry eye or normal tear production was comparable.

Conclusions: : Topical treatment with NTX normalizes tear production in rats with naturally occurring dry eye. Topical application of NTX to the ocular surface may serve as an important strategy for treating dry eye.

Keywords: cornea: tears/tear film/dry eye 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×